Leading Edge Research LA, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Migraine2 trials
• Alzheimer disease1 trial

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• TriGemX Bio, Inc.2 trials
• Suven Life Sciences Limited1 trial

Running trials

• Recruiting

  A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07674654· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Annemarie Vance

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07645924· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Annemarie Vance

• Active, not recruiting

  Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

  NCT05397639· Phase 3· Suven Life Sciences Limited· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Migraine2 recruiting